FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Ortho Trivicta Hip System Cleared

FDA clears an Ortho Development 510(k) for its Trivicta Hip System, a triple-taper femoral stem that is intended to facilitate an optimal fit within t...

latest-news-card-1
Medical Devices

Medos Recalls Cerebase DA Guide Sheath

Johnson & Johnsons Medos International Sarl device unit recalls its Cerebase DA Guide Sheath after receiving an increase in complaints about fractures...

latest-news-card-1
Federal Register

Notice Corrected on Flowtuss NDA Withdrawal

Federal Register notice: FDA corrects a 12/18 notice that announced the withdrawal of a Chartwell RX Sciences NDA for Flowtuss.

latest-news-card-1
Federal Register

Guide on Safety Reporting Standards

Federal Register notice: FDA makes available a draft guidance entitled E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and...

latest-news-card-1
Human Drugs

Damning Report on Alzheimer Drug Tests: Article

A Science investigative report looks at issues found by FDA in a laboratory analysis of results from trials of Cassavas potential Alzheimers drug simu...

latest-news-card-1
Medical Devices

Cassidy Wants Test Regulation Ideas

Republican Sen. Bill Cassidy asks interested parties to submit their ideas for congressional action to reform the regulation of clinical tests.

latest-news-card-1
Human Drugs

FDA Approves Madrigal Fatty Liver Drug

FDA approves a Madrigal Pharmaceuticals NDA for Rezdiffra (resmetirom) for treating adults with noncirrhotic non-alcoholic steatohepatitis.

latest-news-card-1
Human Drugs

Post-Approval Safety Data Reporting Guide

FDA publishes a draft ICH guidance on post-marketing individual case study reporting.

latest-news-card-1
Human Drugs

Advisors to Weigh Imetelstat Benefits, Risks

FDA medical reviewers ask the Oncology Drug Advisory Committee to weigh the benefits of the benefits and serious risks of Gerons imetelstat to treat s...

latest-news-card-1
Human Drugs

ODAC Looking at Increased Deaths in 2 Drugs

FDA asks the Oncologic Drugs Advisory Committee to evaluate the higher risk of early deaths in trials supporting sBLAs for Celgenes Abecma and Janssen...